Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium.
Arteaga-Henríquez G, Simon MS, Burger B, Weidinger E, Wijkhuijs A, Arolt V, Birkenhager TK, Musil R, Müller N, Drexhage HA. Arteaga-Henríquez G, et al. Among authors: muller n. Front Psychiatry. 2019 Jul 9;10:458. doi: 10.3389/fpsyt.2019.00458. eCollection 2019. Front Psychiatry. 2019. PMID: 31354538 Free PMC article.
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms.
Riedel M, Müller N, Strassnig M, Spellmann I, Engel RR, Musil R, Dehning S, Douhet A, Schwarz MJ, Möller HJ. Riedel M, et al. Among authors: muller n. Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):432-7. doi: 10.1007/s00406-005-0622-6. Epub 2005 Nov 4. Eur Arch Psychiatry Clin Neurosci. 2005. PMID: 16267634 Clinical Trial.
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Müller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Müller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Möller HJ, Arolt V, Riedel M. Müller N, et al. Mol Psychiatry. 2006 Jul;11(7):680-4. doi: 10.1038/sj.mp.4001805. Epub 2006 Feb 21. Mol Psychiatry. 2006. PMID: 16491133 Clinical Trial.
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.
Spellmann I, Müller N, Musil R, Zill P, Douhet A, Dehning S, Cerovecki A, Bondy B, Möller HJ, Riedel M. Spellmann I, et al. Among authors: muller n. Eur Arch Psychiatry Clin Neurosci. 2008 Sep;258(6):335-44. doi: 10.1007/s00406-007-0800-9. Epub 2008 Mar 17. Eur Arch Psychiatry Clin Neurosci. 2008. PMID: 18347838 Clinical Trial.
Association between intracellular infectious agents and Tourette's syndrome.
Krause D, Matz J, Weidinger E, Wagner J, Wildenauer A, Obermeier M, Riedel M, Müller N. Krause D, et al. Among authors: muller n. Eur Arch Psychiatry Clin Neurosci. 2010 Jun;260(4):359-63. doi: 10.1007/s00406-009-0084-3. Epub 2009 Nov 5. Eur Arch Psychiatry Clin Neurosci. 2010. PMID: 19890596
Effect of aripiprazole on cognition in the treatment of patients with schizophrenia.
Riedel M, Spellmann I, Schennach-Wolff R, Musil R, Dehning S, Cerovecki A, Opgen-Rhein M, Matz J, Seemüller F, Obermeier M, Severus E, Engel RR, Müller N, Möller HJ. Riedel M, et al. Among authors: muller n. Pharmacopsychiatry. 2010 Mar;43(2):50-7. doi: 10.1055/s-0029-1239539. Epub 2009 Dec 10. Pharmacopsychiatry. 2010. PMID: 20336597 Clinical Trial.
2,406 results